Antifungals: Difference between revisions
From IDWiki
(Imported from text file) |
m (Text replacement - " species]]" to "]]") |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
⚫ | |||
= Antifungals = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
**[[Itraconazole]] |
|||
⚫ | |||
**[[Isavuconazole]] |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
*** Does not require adjustment in hepatic disease? |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
[[Category:Antimicrobials]] |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ |
Latest revision as of 02:48, 8 February 2022
See also Antifungal spectrum of activity
Polyenes
- Mechanism: bind to ergosterol in the cell membrane and create pores
- Examples: Amphotericin B
Triazoles
- Mechanism: inhibit 14-alpha demethylase (aka. Cyp51p, encoded by Erg11 genes), which is required for synthesis of ergosterol from lanosterol, thus disrupting the cell wall.
- Examples
- Fluconazole: Used as prophylaxis or treatment for Candida
- Voriconazole: First-line treatment for invasive aspergillosis
- Itraconazole
- Posaconazole: Second-line treatment for invasive aspergillosis, but first-line for prophylaxis
- Isavuconazole
Echinocandins
- Mechanism: disrupt synthesis of beta-glucan in the cell wall by inhibiting 1,3-beta glucan synthase
- Examples
- Micafungin
- Caspofungin: Febrile neutropenia
- Anidulafungin: ICU (high APACHEII), no renal or hepatic dosing needed